Variant report
Variant | nsv1034326 |
---|---|
Chromosome Location | chr9:11633417-11679525 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140457266 | chr9:11633442-11633443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531127546 | chr9:11633478-11633479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145458695 | chr9:11633507-11633508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368397749 | chr9:11633571-11633572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78500325 | chr9:11633578-11633579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73397510 | chr9:11633580-11633581 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs190501855 | chr9:11633592-11633593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549152421 | chr9:11650217-11650218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185516676 | chr9:11650246-11650247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141616402 | chr9:11650260-11650261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150501430 | chr9:11650262-11650263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566195924 | chr9:11650269-11650270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538365733 | chr9:11650287-11650288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138652451 | chr9:11650314-11650315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568494166 | chr9:11650320-11650321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537481540 | chr9:11650342-11650343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555199584 | chr9:11650351-11650352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527750592 | chr9:11650408-11650409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575043263 | chr9:11650410-11650411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149312386 | chr9:11650424-11650425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116315155 | chr9:11650428-11650429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144574145 | chr9:11650452-11650453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2586380 | chr9:11650459-11650460 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs563010782 | chr9:11650473-11650474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531735595 | chr9:11650488-11650489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547428730 | chr9:11650495-11650496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73397557 | chr9:11650501-11650502 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs139657245 | chr9:11650514-11650515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529959116 | chr9:11650544-11650545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541194482 | chr9:11650545-11650546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532740995 | chr9:11650551-11650552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113725856 | chr9:11650588-11650589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191914081 | chr9:11650593-11650594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550992494 | chr9:11650596-11650597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183299923 | chr9:11650600-11650601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545360576 | chr9:11656016-11656017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369378988 | chr9:11656021-11656022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527969080 | chr9:11656040-11656041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565518026 | chr9:11656046-11656047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113535617 | chr9:11656055-11656056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571049192 | chr9:11656134-11656135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540070382 | chr9:11656200-11656201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556335657 | chr9:11656204-11656205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181439918 | chr9:11656215-11656216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111299406 | chr9:11656232-11656233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186544276 | chr9:11656248-11656249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555360367 | chr9:11656306-11656307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572132630 | chr9:11656312-11656313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540119093 | chr9:11656325-11656326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148818384 | chr9:11656332-11656333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Schizophrenia | 18511947 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11633200-11633600 | Enhancers | Fetal Brain Male | brain |
2 | chr9:11650200-11650600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr9:11656000-11656800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |